Susan Byrne
Susan Byrne
GSTT
Verified email at gstt.nhs.uk
TitleCited byYear
The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study
J Phukan, M Elamin, P Bede, N Jordan, L Gallagher, S Byrne, C Lynch, ...
J Neurol Neurosurg Psychiatry 83 (1), 102-108, 2012
4452012
Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study
S Byrne, M Elamin, P Bede, A Shatunov, C Walsh, B Corr, M Heverin, ...
The Lancet Neurology 11 (3), 232-240, 2012
3492012
Rate of familial amyotrophic lateral sclerosis: a systematic review and meta-analysis
S Byrne, C Walsh, C Lynch, P Bede, M Elamin, K Kenna, R McLaughlin, ...
Journal of Neurology, Neurosurgery & Psychiatry 82 (6), 623-627, 2011
2852011
Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia
M Elamin, J Phukan, P Bede, N Jordan, S Byrne, N Pender, O Hardiman
Neurology 76 (14), 1263-1269, 2011
2272011
Cognitive changes predict functional decline in ALS: a population-based longitudinal study
M Elamin, P Bede, S Byrne, N Jordan, L Gallagher, B Wynne, C O’Brien, ...
Neurology 80 (17), 1590-1597, 2013
1512013
Multiparametric MRI study of ALS stratified for the C9orf72 genotype
P Bede, ALW Bokde, S Byrne, M Elamin, RL McLaughlin, K Kenna, ...
Neurology 81 (4), 361-369, 2013
1172013
Delineating the genetic heterogeneity of ALS using targeted high-throughput sequencing
KP Kenna, RL McLaughlin, S Byrne, M Elamin, M Heverin, EM Kenny, ...
Journal of medical genetics 50 (11), 776-783, 2013
1122013
Proposed criteria for familial amyotrophic lateral sclerosis
S Byrne, P Bede, M Elamin, K Kenna, C Lynch, R McLaughlin, ...
Amyotrophic Lateral Sclerosis 12 (3), 157-159, 2011
1092011
Basal ganglia involvement in amyotrophic lateral sclerosis
P Bede, M Elamin, S Byrne, RL McLaughlin, K Kenna, A Vajda, N Pender, ...
Neurology 81 (24), 2107-2115, 2013
1042013
A multidisciplinary clinic approach improves survival in ALS: a comparative study of ALS in Ireland and Northern Ireland
J Rooney, S Byrne, M Heverin, K Tobin, A Dick, C Donaghy, O Hardiman
J Neurol Neurosurg Psychiatry 86 (5), 496-501, 2015
1002015
Grey matter correlates of clinical variables in amyotrophic lateral sclerosis (ALS): a neuroimaging study of ALS motor phenotype heterogeneity and cortical focality
P Bede, A Bokde, M Elamin, S Byrne, RL McLaughlin, N Jordan, ...
J Neurol Neurosurg Psychiatry 84 (7), 766-773, 2013
972013
Anti-N-methyl-d-aspartate receptor encephalitis: review of clinical presentation, diagnosis and treatment
H Barry, S Byrne, E Barrett, KC Murphy, DR Cotter
BJPsych bulletin 39 (1), 19-23, 2015
892015
Aggregation of neurologic and neuropsychiatric disease in amyotrophic lateral sclerosis kindreds: A population‐based case–control cohort study of familial and sporadic …
S Byrne, M Heverin, M Elamin, P Bede, C Lynch, K Kenna, ...
Annals of neurology 74 (5), 699-708, 2013
802013
Congenital disorders of autophagy: an emerging novel class of inborn errors of neuro-metabolism
D Ebrahimi-Fakhari, A Saffari, L Wahlster, J Lu, S Byrne, GF Hoffmann, ...
Brain 139 (2), 317-337, 2015
592015
Survival analysis of Irish amyotrophic lateral sclerosis patients diagnosed from 1995–2010
J Rooney, S Byrne, M Heverin, B Corr, M Elamin, A Staines, B Goldacre, ...
PloS one 8 (9), e74733, 2013
592013
Earlier treatment of NMDAR antibody encephalitis in children results in a better outcome
S Byrne, C Walsh, Y Hacohen, E Muscal, J Jankovic, A Stocco, RC Dale, ...
Neurology-Neuroimmunology Neuroinflammation 2 (4), e130, 2015
582015
Absence of consensus in diagnostic criteria for familial neurodegenerative diseases
S Byrne, M Elamin, P Bede, O Hardiman
J Neurol Neurosurg Psychiatry 83 (4), 365-367, 2012
552012
Intermediate repeat expansion length in C9orf72 may be pathological in amyotrophic lateral sclerosis
S Byrne, M Heverin, M Elamin, C Walsh, O Hardiman
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 15 (1-2), 148-150, 2014
452014
Patterns of cerebral and cerebellar white matter degeneration in ALS
P Bede, M Elamin, S Byrne, RL McLaughlin, K Kenna, A Vajda, A Fagan, ...
J Neurol Neurosurg Psychiatry 86 (4), 468-470, 2015
412015
Spinal cord markers in ALS: diagnostic and biomarker considerations
P Bede, ALW Bokde, S Byrne, M Elamin, AJ Fagan, O Hardiman
Amyotrophic Lateral Sclerosis 13 (5), 407-415, 2012
362012
The system can't perform the operation now. Try again later.
Articles 1–20